Printer Friendly

NEORX STOCKHOLDERS APPROVE COMMON SHARE INCREASE

 NEORX STOCKHOLDERS APPROVE COMMON SHARE INCREASE
 SEATTLE, Nov. 5 /PRNewswire/ -- NeoRx Corporation (NASDAQ: NERX)


announced today that at a special meeting of shareholders, the company's authorized common stock was increased from 30 million to 60 million shares. Holders of 92 percent of the company's outstanding common stock voted in favor of the increase.
 Paul G. Abrams, president and chief executive officer of NeoRx stated, "We are very gratified that the shareholders overwhelmingly supported the proposed transaction, enabling us to complete our previously announced $10 million private placement. Coupled with the extinguishment of $7 million of our debentures, the balance sheet is the strongest it has been since our IPO in 1988. Despite an increase in research and product development activities, we are operating at the lowest expense level since 1986.
 NeoRx Corporation, incorporated in May 1984, is a leading company developing monoclonal antibody-based pharmaceutical products for in vivo detection and treatment of certain types of cancer. The company has three cancer therapy trials in progress and has filed for marketing approval with the FDA for OncoTrac(R) imaging products to detect metastatic melanoma and small cell lung cancer.
 -0- 11/5/91
 /CONTACT: Robert M. Littauer, vice president, chief financial officer and treasurer of NeoRx, 206-286-2519, or Anthony J. Russo, Ph.D. or Susan A. Noonan of Noonan/Russo Communications, 212-979-9180, for NeoRx/
 (NERX) CO: NeoRx Corporation ST: Washington IN: MTC SU: PS -- NY010 -- 1084 11/05/91 08:27 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 5, 1991
Words:241
Previous Article:CHIQUITA REPORTS EARNINGS
Next Article:SYMBOL TECHNOLOGIES EXPANDS SPREAD-SPECTRUM-BASED PORTABLE TERMINALS; INTRODUCES BAR CODE-BASED PRODUCTS AND EDUCATIONAL PROGRAM
Topics:


Related Articles
NEORX DIVIDEND NOTICE
NEORX ANNOUNCES $9 MILLION FINANCING
NEORX COMPLETES $9 MILLION FINANCING
NEORX CORPORATION $16 MILLION SECONDARY PUBLIC OFFERING; COMPANY REVERSE SPLITS STOCK 1 FOR 4
NEORX ANNOUNCES $7.0 MILLION PRIVATE PLACEMENT OF SECURITIES TO INSTITUTIONAL INVESTORS
NEORX ANNOUNCES $7.0 MILLION PRIVATE PLACEMENT OF SECURITIES TO INSTITUTIONAL INVESTORS
NEORX CORPORATION ADOPTS SHAREHOLDER RIGHTS PLAN
NeoRx Announces New Major Shareholder
NeoRx Converts Preferred Stock Held by Johnson & Johnson Development Corporation

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters